Elixène Jean-Baptiste

Elixène Jean-Baptiste

Auto-generated profile, based on publicly available information

Elixène Jean-Baptiste

Department of Vascular Surgery, University Hospital of Nice, Nice, France

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2014 in Circulation
Verified
Journal Article
Closed access
KSKarl Sörelius
Karl Sörelius
KMKevin Mani
Kevin Mani
MBMartin Björck
Martin Björck
PSPetr Sedivy
Petr Sedivy
CWCarl-Magnus Wahlgren
Carl-Magnus Wahlgren
AWAnders Wanhainen
Anders Wanhainen
Background—: Mycotic aortic aneurysm (MAA) is a rare and life-threatening disease. The aim of this European multicenter collaboration was to study the durability of endovascular aortic repair (EVAR) of MAA, by assessing late infection–related complications and long-term survival. Methods and Results—: All EVAR treated MAAs, between 1999 and 2013 at 16 European centers, were retrospectively reviewed. One hundred twenty-three patients with 130 MAAs were identified. Mean age was 69 years (range 39–86), 87 (71%) were men, 58 (47%) had immunodeficiency, and 47 (38%) presented with rupture. Anatomic locations were ascending/arch (n=4), descending (n=34), paravisceral (n=15), infrarenal aorta (n=63), and multiple (n=7). Treatments were thoracic EVAR (n=43), fenestrated/branched EVAR (n=9), and infrarenal EVAR (n=71). Antibiotic was administered for mean 30 weeks. Mean follow-up was 35 months (range 1 week to 149 months). Six patients (5%) were converted to open repair during follow-up. Survival was 91% (95% confidence interval, 86% to 96%), 75% (67% to 83%), 55% (44% to 66%), and 41% (28% to 54%) after 1, 12, 60, and 120 months, respectively. Infection-related death occurred in 23 patients (19%), 9 after discontinuation of antibiotic treatment. A Cox regression analysis demonstrated non-Salmonella–positive culture as predictors for late infection–related death. Conclusions—: Endovascular treatment of MAA is feasible and for most patients a durable treatment option. Late infections do occur, are often lethal, and warrant long-term antibiotic treatment and follow-up. Patients with non-Salmonella–positive blood cultures were more likely to die from late infection.

1 May 2010 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
SAS. Amiot
S. Amiot
SHS. Haulon
S. Haulon
JBJ.-P. Becquemin
J.-P. Becquemin
PMP.-E. Magnan
P.-E. Magnan
PLP. Lermusiaux
P. Lermusiaux
JFJ.-P. Favre
J.-P. Favre

1 September 2015 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
PDP. Desgranges
P. Desgranges
HKH. Kobeiter
H. Kobeiter
SKS. Katsahian
S. Katsahian
MBM. Bouffi
M. Bouffi
PGP. Gouny
P. Gouny
JBJ.-P. Becquemin
J.-P. Becquemin

1 June 2011 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
MBM. Batt
M. Batt
EJE. Jean-Baptiste
E. Jean-Baptiste
SOS. O’cOnnor
S. O’cOnnor
BSB. Saint-Lebes
B. Saint-Lebes
PFP. Feugier
P. Feugier
SHS. Haulon
S. Haulon

1 August 2008 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
MBM. Batt
M. Batt
EJE. Jean-Baptiste
E. Jean-Baptiste
SOS. O'COnnor
S. O'COnnor
PBP.-J. Bouillanne
P.-J. Bouillanne
PHP. Haudebourg
P. Haudebourg
RFR. Farhad
R. Farhad

1 July 2014 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
EJElixène Jean-Baptiste
Elixène Jean-Baptiste
SBSophie Brizzi
Sophie Brizzi
MBMichel A. Bartoli
Michel A. Bartoli
NSNirvana Sadaghianloo
Nirvana Sadaghianloo
JBJean Baqué
Jean Baqué
RHRéda Hassen-Khodja
Réda Hassen-Khodja